The Oncology Institute Announces Fourth Quarter and Full Year 2023 Earnings Release Date and Conference Call
March 06 2024 - 8:00AM
The Oncology Institute, LLC (“TOI”) (NASDAQ: TOI), one of the
largest value-based oncology groups in the United States, today
announced that the company will release its fourth quarter and full
year 2023 financial results after the market close on Wednesday,
March 27, 2024, to be followed by a conference call the same day at
5:00 p.m. (Eastern Time).
The conference call can be accessed live over the phone by
dialing 1-877-407-0789 or for international callers,
1-201-689-8562. A replay will be available two hours after the call
and can be accessed by dialing 1-844-512-2921, or for international
callers, 1-412-317-6671. The passcode for the live call and the
replay is 13744947. The replay will be available until Wednesday,
April 3, 2024.
Interested investors and other parties may also listen to a
simultaneous webcast of the conference call by logging onto the
Investor Relations section of the Company’s website at
https://investors.theoncologyinstitute.com/.
About The Oncology Institute
Founded in 2007, The Oncology Institute, Inc. (TOI) is advancing
oncology by delivering highly specialized, value-based cancer care
in the community setting. TOI offers cutting-edge, evidence-based
cancer care to a population of more than 1.8 million patients
including clinical trials, transfusions, and other care delivery
models traditionally associated with the most advanced care
delivery organizations. With 110+ employed clinicians and over 70
clinic locations and growing, TOI is changing oncology for the
better. For more information visit
www.theoncologyinstitute.com.
Investors
Solebury Strategic
Communicationsinvestors@theoncologyinstitute.com
Oncology Institute (NASDAQ:TOIIW)
Historical Stock Chart
From Oct 2024 to Nov 2024
Oncology Institute (NASDAQ:TOIIW)
Historical Stock Chart
From Nov 2023 to Nov 2024